This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07783/identifier/pdb/
n4http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB07783/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07783/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07783/identifier/drugbank/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07783/identifier/chemspider/

Statements

Subject Item
n2:DB07783
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB07783 n7:DB07783
dcterms:title
1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE
adms:identifier
n10:99444254 n11:FR4 n12:448903 n13:395565 n14:DB07783
n5:IUPAC-Name
n6:271B3EBB-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B3EC1-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B3EC0-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B3EBD-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B3EBE-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B3EBF-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B3EB9-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B3EBA-363D-11E5-9242-09173F13E4C5 n6:271B3EB7-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B3EB8-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B3EC7-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B3EC8-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B3EC2-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B3EC3-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B3EC5-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B3EC4-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B3EC6-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B3ECD-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B3ECF-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B3ED0-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B3ECC-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B3ECB-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B3ECE-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B3EBC-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B3EC9-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B3ECA-363D-11E5-9242-09173F13E4C5